NASDAQ:HSCS Heart Test Laboratories (HSCS) Stock Price, News & Analysis $2.85 +0.01 (+0.39%) Closing price 03/28/2025 03:58 PM EasternExtended Trading$2.80 -0.05 (-1.61%) As of 03/28/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About Heart Test Laboratories Stock (NASDAQ:HSCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HSCS alerts:Sign Up Key Stats Today's Range$2.75▼$2.9650-Day Range$2.84▼$3.9952-Week Range$2.36▼$13.50Volume4,411 shsAverage Volume127,876 shsMarket Capitalization$3.08 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingBuy Company OverviewHeart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Read More… Remove Ads Heart Test Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreHSCS MarketRank™: Heart Test Laboratories scored higher than 60% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingHeart Test Laboratories has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageHeart Test Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Heart Test Laboratories' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Heart Test Laboratories are expected to grow in the coming year, from ($10.01) to ($8.80) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Heart Test Laboratories is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Heart Test Laboratories is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHeart Test Laboratories has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.28% of the float of Heart Test Laboratories has been sold short.Short Interest Ratio / Days to CoverHeart Test Laboratories has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Heart Test Laboratories has recently decreased by 2.43%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHeart Test Laboratories does not currently pay a dividend.Dividend GrowthHeart Test Laboratories does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.28% of the float of Heart Test Laboratories has been sold short.Short Interest Ratio / Days to CoverHeart Test Laboratories has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Heart Test Laboratories has recently decreased by 2.43%, indicating that investor sentiment is improving. News and Social Media3.3 / 5News Sentiment0.98 News SentimentHeart Test Laboratories has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Heart Test Laboratories this week, compared to 0 articles on an average week.MarketBeat Follows2 people have added Heart Test Laboratories to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Heart Test Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.80% of the stock of Heart Test Laboratories is held by insiders.Percentage Held by InstitutionsOnly 17.24% of the stock of Heart Test Laboratories is held by institutions.Read more about Heart Test Laboratories' insider trading history. Receive HSCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address HSCS Stock News HeadlinesAscendiant Capital Markets Weighs in on HSCS Q4 EarningsMarch 23, 2025 | americanbankingnews.comHeart Test Laboratories (NASDAQ:HSCS) Given New $14.00 Price Target at Ascendiant Capital MarketsMarch 20, 2025 | americanbankingnews.comTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.March 29, 2025 | Porter & Company (Ad)Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial ResultsMarch 14, 2025 | finanznachrichten.deHeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial ResultsMarch 13, 2025 | globenewswire.comHeartSciences engages Integrous Communications to enhance communicationsMarch 10, 2025 | markets.businessinsider.comHeartSciences Inc. Engages Integrous Communications to Enhance Investor CommunicationsMarch 10, 2025 | globenewswire.comHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial ResultsDecember 16, 2024 | globenewswire.comSee More Headlines HSCS Stock Analysis - Frequently Asked Questions How have HSCS shares performed this year? Heart Test Laboratories' stock was trading at $3.82 on January 1st, 2025. Since then, HSCS stock has decreased by 25.4% and is now trading at $2.8510. View the best growth stocks for 2025 here. How were Heart Test Laboratories' earnings last quarter? Heart Test Laboratories, Inc. (NASDAQ:HSCS) posted its earnings results on Thursday, March, 13th. The company reported ($2.57) EPS for the quarter, missing analysts' consensus estimates of ($2.53) by $0.04. When did Heart Test Laboratories' stock split? Heart Test Laboratories's stock reverse split on the morning of Friday, May 17th 2024. The 1-100 reverse split was announced on Friday, May 17th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did Heart Test Laboratories IPO? Heart Test Laboratories (HSCS) raised $9 million in an initial public offering (IPO) on Wednesday, June 15th 2022. The company issued 1,800,000 shares at $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO. How do I buy shares of Heart Test Laboratories? Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Heart Test Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Heart Test Laboratories investors own include Meta Platforms (META), Cardio Diagnostics (CDIO), Invesco QQQ (QQQ), RH (RH), Exxon Mobil (XOM), Amarin (AMRN) and American Express (AXP). Company Calendar Last Earnings3/13/2025Today3/29/2025Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:HSCS CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployees10Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$14.00 Low Stock Price Target$12.00 Potential Upside/Downside+356.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($7.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,610,000.00 Net MarginsN/A Pretax Margin-50,833.34% Return on Equity-117.76% Return on Assets-84.09% Debt Debt-to-Equity Ratio0.01 Current Ratio1.72 Quick Ratio1.52 Sales & Book Value Annual Sales$14,700.00 Price / Sales209.66 Cash FlowN/A Price / Cash FlowN/A Book Value$11.16 per share Price / Book0.26Miscellaneous Outstanding Shares1,081,000Free Float962,000Market Cap$3.08 million OptionableNot Optionable Beta2.77 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:HSCS) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.